Disclosures for "Determining the LVO Denominator: Estimating the Proportion of Large Vessel Ischemic Strokes When CTA is Unavailable"
-
Ms. Iyyangar has nothing to disclose.
-
Kimberly Geronimo has nothing to disclose.
-
Deepa Dongarwar, MS has nothing to disclose.
-
Mr. Ballekere has nothing to disclose.
-
Ms. Le has nothing to disclose.
-
Mr. Azeem has nothing to disclose.
-
Miss Abdelkhaleq has nothing to disclose.
-
Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology - Neurology Clinical Practice Journal. . The institution of Dr. Jagolino-Cole has received research support from McGovern Medical School at the University of Texas Health Science Center at Houston.
-
Jo Ann Soliven has nothing to disclose.
-
Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
-
Dr. Aroor has nothing to disclose.